CGM
AMAG

Capital Growth Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Capital Growth Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-472,000
Closed -$18.8M – 76
2015
Q3 		$18.8M Sell
472,000
-50,000
-10% -$3.1M 0.6% 39
2015
Q2 		$36M Hold
522,000
– – 1.03% 28
2015
Q1 		$28.5M Hold
522,000
– – 0.78% 33
2014
Q4 		$22.2M Buy
+522,000
New +$18.9M 0.61% 42

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital Growth Management's AMAG Position: Q4 2015 in Review

Capital Growth Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2015, closing a stake of 472,000 shares — an estimated $18.8M sold.

Capital Growth Management first reported a position in AMAG in Q4 2014 and held it in 4 quarters. The position peaked at $36M in Q2 2015. 172 funds tracked by Wall St. Rank hold AMAG as of Q4 2015.

  • Capital Growth Management reported no remaining AMAG Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Capital Growth Management sold 472,000 AMAG Pharmaceuticals shares in Q4 2015, an estimated $18.8M.
  • Capital Growth Management first reported a position in AMAG Pharmaceuticals in Q4 2014 and held it in 4 quarters.
  • Capital Growth Management's AMAG Pharmaceuticals position peaked at $36M in Q2 2015.
  • 172 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2015.

Based on Capital Growth Management's 13F filing for Q4 2015, filed 12 Feb 2016.